Longevity Health Holdings Inc.

XAGE · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$11,803-$15,445-$9,051-$6,479
Dep. & Amort.$197$125$243$242
Deferred Tax$0$0-$195$2,515
Stock-Based Comp.$827$668$636$247
Change in WC$669-$3,422$2,339$953
Other Non-Cash$5,720$9,727$2,218$1,345
Operating Cash Flow-$4,389-$8,348-$3,429-$1,177
Investing Activities
PP&E Inv.$0-$30-$7-$7
Net Acquisitions-$749$0$0$0
Inv. Purchases$0$0$0-$154,441
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$154,441
Investing Cash Flow-$749-$30-$7-$7
Financing Activities
Debt Repay.-$218-$3,202$2,746$1,124
Stock Issued$2,687$41$0$3
Stock Repurch.$0$0-$2$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$86$14,324$1,190$68
Financing Cash Flow$2,382$11,163$3,934$1,195
Forex Effect$0$0$0$0
Net Chg. in Cash-$2,755$2,784$116$11
Supplemental Information
Beg. Cash$2,912$128$12$1
End Cash$157$2,912$128$12
Free Cash Flow-$4,389-$8,379-$3,436-$1,184
Longevity Health Holdings Inc. (XAGE) Financial Statements & Key Stats | AlphaPilot